The regenerative medicine sector has long promised transformative therapeutic interventions, yet commercial viability remained elusive for decades. Recent developments suggest the field has reached a critical inflection point where cellular therapy technologies transition from experimental protocols to scalable clinical applications. Companies like Celljevity, with their Prometheus Cell therapy demonstrating consistentContinue Reading

Sign up for the View from Westminster email for expert analysis straight to your inbox Get our free View from Westminster email Get our free View from Westminster email Rachel Reeves appeared to pave the way for significant tax increases in a major pre-Budget speech, as she said “easy answers”Continue Reading